These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18825132)

  • 1. Are female lower urinary tract symptoms alleviated by alpha-adrenoreceptor antagonists?
    Andersson KE
    Nat Clin Pract Urol; 2008 Nov; 5(11):586-7. PubMed ID: 18825132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.
    Low BY; Liong ML; Yuen KH; Chee C; Leong WS; Chong WL; Khan NA; Cheah PY; Liong KK
    J Urol; 2008 Apr; 179(4):1461-9. PubMed ID: 18295277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
    Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
    Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
    Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gallegos PJ; Frazee LA
    Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of voiding parameters in men and women with lower urinary tract symptoms.
    Ku JH; Oh SJ
    Neurourol Urodyn; 2006; 25(1):13-8. PubMed ID: 16049917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effect of alpha 1D/A adrenoceptor inhibitor naftopidil on benign prostatic hyperplasia: an international prostate symptom score and King's Health Questionnaire assessment.
    Awa Y; Suzuki H; Hamano S; Okano T; Sakurayama Y; Ohki T; Egoshi K; Ota S; Mori I; Ichikawa T
    Int J Urol; 2008 Aug; 15(8):709-15. PubMed ID: 18662175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower urinary tract symptoms.
    Gammack JK
    Clin Geriatr Med; 2010 May; 26(2):249-60. PubMed ID: 20497844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders.
    Okamura K; Nojiri Y; Osuga Y
    BJU Int; 2009 Jun; 103(12):1673-8. PubMed ID: 19154505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial.
    Liu H; Liu P; Mao G; Chen G; Wang B; Qin X; Na Y; Liu Z; Wang X; Xu X
    Urology; 2009 Jul; 74(1):130-6. PubMed ID: 19371934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decision aid for GPs for the treatment of elderly male patients with lower urinary tract symptoms (LUTS).
    Norg RJ; Portegijs PJ; van de Beek K; van Schayck O; Knottnerus JA
    Fam Pract; 2006 Dec; 23(6):666-73. PubMed ID: 16971394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
    Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
    BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy.
    Crawford ED; Kavanagh BD
    Am J Clin Oncol; 2006 Oct; 29(5):517-23. PubMed ID: 17023790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urodynamic criteria of predicting efficacy of therapy with alpha1-adrenergic blockaders in patients with benign prostatic hyperplasia].
    Sivkov AV; Egorov AA; Romikh VV; Surikov VN
    Urologiia; 2002; (5 Suppl):13-22. PubMed ID: 12518669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of sympathetic alpha antagonists in the management of pediatric urologic disorders.
    Husmann DA
    Curr Opin Urol; 2006 Jul; 16(4):277-82. PubMed ID: 16770128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study.
    Wang CJ; Huang SW; Chang CH
    Urol Int; 2009; 83(1):66-9. PubMed ID: 19641362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume.
    Gomes CM; Nunes RV; Araújo RM; Sacomani CR; Trigo-Rocha FE; Bruschini H; Srougi M
    Urol Int; 2008; 81(2):129-34. PubMed ID: 18758208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.